Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases

Clicks: 413
ID: 9946
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #5 of 31 articles by views in case reports in surgery

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Introduction. We herein present three cases of locally advanced colon cancer (LACC) invading the urinary bladder, in whom combined neoadjuvant chemotherapy with surgical intervention was effective in disease control and preserving urinary function. Case Presentation. Before neoadjuvant chemotherapy, all three cases underwent loop transverse colostomy for symptomatic colonic obstruction. Case 1: after 6 courses of capecitabine plus oxaliplatin (CAPOX), we performed sigmoid colectomy and partial resection of the bladder. The histological examination revealed pathological complete response (pCR). The final diagnosis was ypStage 0 (ypT0ypN0M0). Case 2: after 13 courses of CAPOX plus bevacizumab, we performed Hartmann’s operation with partial resection of the bladder. The histological examination revealed pCR. The final diagnosis was ypStage 0 (ypT0ypN0M0). Case 3: after 6 courses of chemotherapy with CAPOX plus bevacizumab, we performed sigmoid colectomy and partial resection of the bladder. The pathological response was grade 1a according to the Japanese Classification of Colorectal Carcinoma. The final diagnosis was ypStage IIC (ypT4bypN0M0). All three cases underwent capecitabine-based adjuvant chemotherapy after radical surgery and patients are alive without recurrence. Conclusion. Neoadjuvant chemotherapy with CAPOX with or without bevacizumab followed by radical surgery could be an effective treatment option for LACC invading the urinary bladder.
Reference Key
tsutomu2019efficacycase Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Takenami, Tsutomu;Tsujinaka, Shingo;Takahashi, Jun;Tamaki, Sawako;Maemoto, Ryo;Fukuda, Rintaro;Ishikawa, Hideki;Kakizawa, Nao;Hasegawa, Fumi;Kikugawa, Rina;Miyakura, Yasuyuki;Suzuki, Koichi;Tanaka, Akira;Rikiyama, Toshiki;Takenami, Tsutomu;Tsujinaka, Shingo;Takahashi, Jun;Tamaki, Sawako;Maemoto, Ryo;Fukuda, Rintaro;Ishikawa, Hideki;Kakizawa, Nao;Hasegawa, Fumi;Kikugawa, Rina;Miyakura, Yasuyuki;Suzuki, Koichi;Tanaka, Akira;Rikiyama, Toshiki;
Journal case reports in surgery
Year 2019
DOI
10.1155/2019/8129358
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.